Advertisement

Organisation › Details
Orion Pharma GmbH
![]() |
Start | 1997-01-01 existent |
Group | Orion Corporation (Group) | |
![]() |
Industry | pharmaceutical |
![]() |
Region | Hamburg |
Country | Germany | |
City | n. a. Hamburg | |
Address record changed: 2011-05-15 | ||
Basic data | Employees | n. a. |
Record changed: 2025-03-16 |
Advertisement

More documents for Orion Corporation (Group)
- [1] Orion Corporation. (1/31/20). "Press Release: Positive CHMP Opinion for Darolutamide as a New Treatment for Men with Non-metastatic Castration-resistant Prostate Cancer"....
- [2] Orion Corporation. (1/23/20). "Press Release: Marketing Authorization Granted for Darolutamide in Japan"....
- [3] Genedata AG. (9/11/19). "Press Release: Orion Pharmaceuticals Implements Genedata Biologics to Support New Large-Molecule R&D Initiative". Basel....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement

» top